Coronavirus, Hepatitis and Liver Disease
COVID-19 Vaccine FAQs - Hepatitis and Liver Disease
Updated 20th October 2021 COVID-19 Vaccine: Hepatitis and Liver Disease Booking a vaccination Eligible people…Read Article
Communication and Nurses Important to Service Delivery Post COVID-19
Hepatitis Queensland's recent online forum uncovered a number of insights into viral hepatitis service delivery…Read Article
Bridging the Gap Forum Insights and Video Now Available
In response to the COVID-19 pandemic, Hepatitis Queensland facilitated a virtual forum to hear how…Read Article
Hepatitis Australia has developed a Coronavirus COVID-19 factsheet to assist those living with hepatitis B and hepatitis C, or chronic conditions caused by a previous hepatitis C infection.
The University of Oxford has started a universal registry to collect data on patients with liver disease (at any stage) and COVID-19. It takes only 5 minutes to submit a case report.
The Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) has created a national taskforce to respond to the impact of COVID-19 on HIV, viral hepatitis and other blood-borne viruses (BBVs) in Australia. The taskforce aims to provide consistent and evidence-based messaging to the BBV health workforce, sector partners and affected communities.
Bulletins from the Taskforce are issued weekly on Thursdays, as well as urgent updates when deemed relevant to the sector. If you want to provide feedback or have any questions regarding the Taskforce please email email@example.com.
- Taskforce portal
- Hepatitis B – ASHM COVID-19 Taskforce interim recommendations regarding COVID-19 and adults living with chronic hepatitis B
- Hepatitis C – ASHM COVID-19 Taskforce interim recommendations regarding COVID-19 and adults living with hepatitis C, or the complications of previous hepatitis C infection
EASL COVID-19 Toolkit for liver patient associations
This accompanying toolkit provides offers step-by-step advice on: helping patient associations to communicate accurate information about COVID-19 to patients advising on the use of social media and newsletters to make communication with patients easier tips on how advocacy can be used to improve the situation and treatment of liver disease patients.
What are the risks of coronavirus COVID-19 for people living with hepatitis B, hepatitis C and/or liver disease?
The following groups could be at higher risk of serious illness from COVID-19:
- people with weakened immune systems (e.g. people on immune-suppressing medications, people receiving cancer treatments)
- elderly people – the risk becomes significantly greater in those aged over 70 years
- Aboriginal and Torres Strait Islander people
- people with chronic medical conditions.
This information suggests some people living with hepatitis B, hepatitis C and/or liver disease could be at greater risk of serious health complications if they become infected with COVID-19. In particular, if you have had hepatitis B or hepatitis C for some time, and/or have developed advanced liver diseases (including cirrhosis) this makes severe COVID-19 illness more likely. This includes people who have ongoing health conditions as a result of a previous hepatitis C infection which has been cured.
What can you do to protect yourself if you have hepatitis B, hepatitis C and or liver disease?
If you have hepatitis B, hepatitis C, advanced liver disease or have previously had hepatitis C, take special care to prevent COVID-19 infection. It is a good reminder to consider asking your doctor for a liver health check if you have not had one in the last six months. Be vigilant and use basic measures to protect yourself against COVID-19 and consult a healthcare provider if in doubt about your risk, especially if you have been around someone who has travelled overseas recently.
People with significant liver disease are recommended to receive vaccinations against influenza and pneumococcal disease. These are funded for people aged 65 and over, and influenza vaccine is funded for all people with chronic liver disease. It is a good idea to make an appointment with your GP to discuss vaccination now. If you are a smoker, Cigarette smoking also increases the risk of severe respiratory illness, and quitting smoking may reduce your chances of complications due to COVID-19.
If you are currently taking treatment for hepatitis B or hepatitis C, or other chronic conditions, it is recommended to ensure you have an adequate stock of your medication to reduce unnecessary visits to health services or pharmacies.”
If you have any concerns please contact a healthcare provider, particularly if you are feeling unwell or have been in contact with someone who is feeling unwell.
GP visits via video
It may be possible for you to attend non-COVID consultations with your GP or specialist via video. This may be available for people living with viral hepatitis and liver disease who are:
- aged over 70
- Aboriginal and Torres Strait Islander people aged over 50
- living with chronic health conditions or who are immunocompromised
- parents with new babies and people who are pregnant
- isolating at home on the advice of a medical practitioner.
Please check with your GP or specialist if they are offering this service.
We will continue to update you as new information becomes available.
- Hepatitis Australia: Coronavirus COVID-19 factsheet for people with hepatitis B and hepatitis C
- Gastroenterological Society of Australia: Impact of COVID-19 on patients with gastrointestinal or liver disorders
- World Hepatitis Alliance COVID-19 Hub
- National Coronavirus Health Information Hotline – 1800 020 080
- Queensland Government Community Recovery Hotline – 1800 173 349
- Queensland Health: Novel Coronavirus information
- Australian Government: Coronavirus health alert
- Hepatitis South Australia COVID-19 Resource Library
- COVID-19 Management Plan for Aboriginal and Torres Strait Islander populations
- Translated COVID-19 Resources
- Hepatitis Queensland: Watch our handwashing video